21 C.F.R. § 355.55

Principal display panel of all fluoride rinse drug products.

Last amended: 2016Year: 2026Length: 29 wordsOfficial source

Cite as 21 C.F.R. § 355.55 (2026)

In addition to the statement of identity required in § 355.50, the following statement shall be prominently placed on the principal display panel: “IMPORTANT: Read directions for proper use.”
Cross-references to the CFR
355.50
21 C.F.R. § 355.55: Principal display panel of all fluoride rinse drug products. | Justis AI